Associate
James's experience includes prosecution before the U.S. Patent and Trademark Office (USPTO) and in several foreign jurisdictions, performing patentability, invalidity, and freedom-to-operate analyses, and assisting with litigation before the U.S. International Trade Commission (ITC). He has a broad range of technical experience in the areas of organic and medicinal chemistry. Prior to joining Finnegan, he was a senior scientist in the chemical development group of Boehringer Ingelheim, where he developed robust and scalable chemical processes to support deliveries of pharmaceutical candidates.
James's doctoral research concerned the development of new methods for the synthesis of small molecules, including biologically active natural products and pharmaceuticals. As an undergraduate, he researched the applications of titanium catalysis in organic synthesis. James also completed a research internship in medicinal chemistry at a research-based biopharmaceutical company, where he prepared novel small molecule compounds of therapeutic interest.
Event
Patent Inventorship: Best Practices for Determination and Correction Patent Inventorship: Best Practices for Determination and Correction
May 7, 2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.